What factors are driving life sciences FDI in 2022?
Pharmaceutical Technology
JULY 28, 2022
Investing in areas that have demonstrated a good track record of success for similar companies is a simple way to reduce risk, but in 2022, companies should be careful of investing in overly populated life sciences clusters, which might be too competitive. Download the white paper ‘Charleston, USA: A life sciences hub’ here.
Let's personalize your content